These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22503062)

  • 1. Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice.
    Lubamba B; Huaux F; Lebacq J; Marbaix E; Dhooghe B; Panin N; Wallemacq P; Leal T
    J Cyst Fibros; 2012 Jul; 11(4):266-73. PubMed ID: 22503062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.
    Dhooghe B; Noël S; Bouzin C; Behets-Wydemans G; Leal T
    PLoS One; 2013; 8(10):e77314. PubMed ID: 24204804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.
    Meyer M; Huaux F; Gavilanes X; van den Brûle S; Lebecque P; Lo Re S; Lison D; Scholte B; Wallemacq P; Leal T
    Am J Respir Cell Mol Biol; 2009 Nov; 41(5):590-602. PubMed ID: 19244203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
    Lubamba B; Lecourt H; Lebacq J; Lebecque P; De Jonge H; Wallemacq P; Leal T
    Am J Respir Crit Care Med; 2008 Mar; 177(5):506-15. PubMed ID: 18006891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.
    Legssyer R; Huaux F; Lebacq J; Delos M; Marbaix E; Lebecque P; Lison D; Scholte BJ; Wallemacq P; Leal T
    Respir Res; 2006 Oct; 7(1):134. PubMed ID: 17064416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
    Noel S; Panin N; Beka M; Dhooghe B; Huaux F; Leal T
    Clin Sci (Lond); 2017 Jun; 131(11):1107-1121. PubMed ID: 28196856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice.
    Lubamba B; Lebacq J; Reychler G; Marbaix E; Wallemacq P; Lebecque P; Leal T
    Eur Respir J; 2011 Jan; 37(1):72-8. PubMed ID: 20562123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis.
    Huaux F; Noel S; Dhooghe B; Panin N; Lo Re S; Lison D; Wallemacq P; Marbaix E; Scholte BJ; Lebecque P; Leal T
    PLoS One; 2013; 8(5):e64341. PubMed ID: 23734196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid.
    Freedman SD; Weinstein D; Blanco PG; Martinez-Clark P; Urman S; Zaman M; Morrow JD; Alvarez JG
    J Appl Physiol (1985); 2002 May; 92(5):2169-76. PubMed ID: 11960971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CFTR negatively regulates cyclooxygenase-2-PGE(2) positive feedback loop in inflammation.
    Chen J; Jiang XH; Chen H; Guo JH; Tsang LL; Yu MK; Xu WM; Chan HC
    J Cell Physiol; 2012 Jun; 227(6):2759-66. PubMed ID: 21913191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
    Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
    Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.
    Haston CK; Cory S; Lafontaine L; Dorion G; Hallett MT
    Physiol Genomics; 2006 Apr; 25(2):336-45. PubMed ID: 16614460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.
    Bruscia EM; Zhang PX; Barone C; Scholte BJ; Homer R; Krause DS; Egan ME
    Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(8):L711-9. PubMed ID: 26851259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2005 Feb; 115(2):405-11. PubMed ID: 15696103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931.
    Veltman M; Stolarczyk M; Radzioch D; Wojewodka G; De Sanctis JB; Dik WA; Dzyubachyk O; Oravecz T; de Kleer I; Scholte BJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L1000-L1014. PubMed ID: 27663991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
    Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
    J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.